Sonia Gatius Caldero
Grado: Doctor/a
973 705312
sgatius.lleida.ics(ELIMINAR)@gencat.cat
Grupos
Publicaciones
-
Albertí-Valls M; Megino-Luque C; Macià A; Gatius S; Matias-Guiu X; Eritja N
Metabolomic-Based Approaches for Endometrial Cancer Diagnosis and Prognosis: A Review.
Cancers 16 -. .
-
Gatius S; Matias Guiu X; Davidson B
Molecular features for timely cancer diagnosis and treatment - tumors of the ovary, fallopian tube and endometrium.
VIRCHOWS ARCHIV 484 339-351. .
-
Dorca, E; Velasco, A; Varela, M; Gatius, S; Villatoro, S; Fullana, N; Cuevas, D; Vaquero, M; Birnbaum, A; Neumann, K; Matias-Guiu, X
Validation of Modaplex POLE mutation assay in endometrial carcinoma
VIRCHOWS ARCHIV 483 787-794. .
-
Polanco, D; Pinilla, L; Gracia-Lavedan, E; Gatius, S; Zuil, M; Pardina, M; Gomez, S; Barbe, F
Performance of endobronchial ultrasound transbronchial needle aspiration as the first nodal staging procedure for the determination of programmed death ligand-1 expression in non-small cell lung cancer patients
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 149 12459-12468. .
-
Navaridas, R; Vidal-Sabanés, M; Ruiz-Mitjana, A; Altés, G; Perramon-Güell, A; Yeramian, A; Egea, J; Encinas, M; Gatius, S; Matias-Guiu, X; Dolcet, X
In Vivo Intra-Uterine Delivery of TAT-Fused Cre Recombinase and CRISPR/Cas9 Editing System in Mice Unveil Histopathology of Pten/p53-Deficient Endometrial Cancers
Advanced Science 10 -. .
-
Matas-Nadal C; Bech-Serra JJ; Gatius S; Gomez X; Ribes-Santolaria M; Guasch-Vallés M; Pedraza N; Casanova JM; Gómez CT; Garí E; Aguayo-Ortiz RS
Biomarkers found in the tumor interstitial fluid may help explain the differential behavior among keratinocyte carcinomas.
MOLECULAR & CELLULAR PROTEOMICS 22 100547-100547. .
-
Lopez-Mejia IC; Pijuan J; Navaridas R; Santacana M; Gatius S; Velasco A; Castellà G; Panosa A; Cabiscol E; Pinyol M; Coll L; Bonifaci N; Peña LP; Vidal A; Villanueva A; Gari E; Llobet-Navàs D; Fajas L; Matias-Guiu X; Yeramian A
Oxidative stress-induced FAK activation contributes to uterine serous carcinoma aggressiveness.
MOLECULAR ONCOLOGY 17 98-118. .
-
Matas-Nadal C; Soria X; Gonzalez-Farré M; Baradad M; Tuset N; Rius Riu F; González M; Gatius S; Vilardell F; López-Ortega R; María Martí R
Abdominal tumors in patients with neurofibromatosis type I: Genotype-phenotype relationships.
European Journal of Medical Genetics 65 104609-104609. .
-
Egan D; Moran B; Wilkinson M; Pinyol M; Guerra E; Gatius S; Matias-Guiu X; Kolch W; le Roux CW; Brennan DJ
CRABP2 - A novel biomarker for high-risk endometrial cancer.
GYNECOLOGIC ONCOLOGY 167 314-322. .
-
Gatius S; Jove M; Megino-Luque C; Albertí-Valls M; Yeramian A; Bonifaci N; Piñol M; Santacana M; Pradas I; Llobet-Navas D; Pamplona R; Matías-Guiu X; Eritja N
Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer.
Cancers 14 -. .
-
Megino-Luque, Cristina; Siso, Pol; Mota-Martorell, Natalia; Navaridas, Raul; de la Rosa I; Urdanibia, Izaskun; Alberti-Valls, Manel; Santacana, Maria; Pinyol, Miquel; Bonifaci, Nuria; Macia, Anna; Llobet-Navas, David; Gatius, Sonia; Matias-Guiu, Xavier; Eritja, Nuria
ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma.
MOLECULAR ONCOLOGY 16 2235-2259. .
-
Gatius, S; Velasco, A; Varela, M; Cuatrecasas, M; Jares, P; Setaffy, L; Bonhomme, B; Santon, A; Lindemann, K; Croce, S; Davidson, B; Lax, S; Palacios, J; Matias-Guiu, X
Comparison of the Idylla™ MSI assay with the Promega™ MSI Analysis System and immunohistochemistry on formalin-fixed paraffin-embedded tissue of endometrial carcinoma: results from an international, multicenter study.
VIRCHOWS ARCHIV 480 1031-1039. .
Proyectos
- Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
- Clinical and functional identification of metastatic colonization biomarkers.
- Papel de ARID1A en la carcinogénesis endometrial dependiente de contexto. Análisis de los mecanismos moleculares y posibles implicaciones terapéuticas
- Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
- EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
- Incorporación de nuevas areas temáticas y nuevos grupos al consorcio CIBER
- Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
- IMPLEMENTATION OF PERSONALIZE MEDICINE IN CUTANEOUS MELANOMA BASED ON GENOMIC SUSCEPTIBILITY AND TUMOR SIGNATURES: IDENTIFICATION OF NEW TARGETS FOR MELANOMA TREATMENT
- VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU
- Estudio metabolómico del carcinoma de endometrio en relación a parametros morfológicos y moleculares